PROTHROMBIN COMPLEX CONCENTRATE FOR RAPID REVERSAL OF WARFARIN-INDUCED ANTICOAGULATION AND INTRACEREBRAL HEMORRHAGE IN PATIENTS SUPPORTED BY A LEFT VENTRICULAR ASSIST DEVICE

被引：7
|
作者：
Takahashi, Ayako [1 ]
Kato, Tomoko S. [1 ,2 ]
Oda, Noboru [1 ,2 ]
Komamura, Kazuo [1 ,2 ]
Kanzaki, Hideaki [1 ]
Asakura, Masaki [1 ]
Hashimura, Kazuhiko [1 ]
Niwaya, Kazuo [3 ]
Funatsu, Toshiaki [3 ]
Nakatani, Takeshi [2 ]
Kobayashi, Junjiro [3 ]
Kitamura, Soichiro [3 ]
Shishido, Toshiaki [4 ]
Miyata, Shigeki [5 ]
Takahashi, Jun C. [6 ]
Iihara, Koji [6 ]
Kitakaze, Masafumi [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Organ Transplantat, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka 5658565, Japan
[4] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Osaka 5658565, Japan
[5] Natl Cerebral & Cardiovasc Ctr, Dept Blood Transfus, Osaka 5658565, Japan
[6] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Osaka 5658565, Japan
来源：
INTERNATIONAL JOURNAL OF GERONTOLOGY | 2010年 / 4卷 / 03期
关键词：
anticoagulants; cerebral hemorrhage; heart-assist devices; heart transplantation; prothrombin complex concentrate; INTRACRANIAL HEMORRHAGE; FACTOR VIIA; THERAPY; MANAGEMENT;
D O I：
10.1016/S1873-9598(10)70038-7
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Background: Intracerebral hemorrhage (ICH) is one of the most serious complications in patients supported by a left ventricular assist device (LVAD). We evaluate the efficacy of prothrombin complex concentrate (PCC) for rapid reversal of warfarin-induced anticoagulation in this population. Methods: A total of 38 consecutive ICH events in patients supported by an LVAD between 1996 and 2007 were retrospectively reviewed. Fourteen ICH events were treated with fresh frozen plasma (FFP) (Group FFP) and 24 ICH events were treated with PCC (Group PCC). The efficacy and outcome of PCC administration versus FFP were evaluated. Results: The proportion of patients surviving after an ICH event was significantly smaller in Group FFP than Group PCC (35.7% vs. 75.0%, p<0.05). None of the patients in Group FFP were able to undergo heart transplantation, whereas 21.4% patients in Group PCC successfully underwent heart transplantation. Conclusion: Patients on LVAD are in need for intensified anticoagulation and are at high risk of ICH; therefore, adequate use of PCC in the event of ICH could be of importance for survival and allow subsequent heart transplantation. [International Journal of Gerontology 2010; 4(3): 143-147]
引用
收藏
页码：143 / 147
页数：5
相关论文
共 50 条
  • [21] Anticoagulation Reversal Strategies for Left Ventricular Assist Device Patients Presenting with Acute Intracranial Hemorrhage
    Wong, Joshua K.
    Chen, Peter C.
    Falvey, Jennifer
    Melvin, Amber L.
    Lidder, Alcina K.
    Lowenstein, Lisa M.
    Miranpuri, Amrendra S.
    Knight, Peter A.
    Massey, H. Todd
    ASAIO JOURNAL, 2016, 62 (05) : 552 - 557
  • [22] Evaluation of Prothrombin Complex Concentrate on Oral Anticoagulation Associated Intracerebral Hemorrhage
    Thuy Nguyen
    Samuel, Sophie
    Reddy, Sujan
    Olowu, Adeola
    Moser, Hope
    Gonzales, Nicole
    NEUROLOGY, 2018, 90
  • [23] THREE-VERSUS FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF WARFARIN-INDUCED BLEEDING
    Holt, Tara
    Taylor, Scott
    Abraham, Prasad
    McMillian, Wesley
    Elder, Tai
    Harris, Serena
    Curtis, Jim
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [24] Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage
    Carothers, Chancey
    Giancarelli, Amanda
    Ibrahim, Joseph
    Hobbs, Brandon
    JOURNAL OF SURGICAL RESEARCH, 2018, 223 : 183 - 187
  • [25] Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate
    Deveras, RAE
    Kessler, CM
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) : 884 - 888
  • [26] High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage
    Merchan, Cristian
    Ahuja, Tania
    Raco, Veronica
    Lewis, Ariane
    NEUROHOSPITALIST, 2020, 10 (01): : 16 - 21
  • [27] Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation
    Boswell, Michael R.
    Stulak, John M.
    Tchantchaleishvili, Vakhtang
    Weber, Matthew P.
    Warner, Matthew A.
    Smith, Bradford B.
    Smith, Mark M.
    ARTIFICIAL ORGANS, 2021, 45 (08) : O223 - O235
  • [28] Reversal of Warfarin Anticoagulation with Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke
    Jalini, Shirin
    Jin, Albert Y.
    Taylor, Sean W.
    CEREBROVASCULAR DISEASES, 2012, 33 (06) : 597 - 597
  • [29] Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1420): : 53 - 54
  • [30] Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage
    Ryan M. Rivosecchi
    Joseph Durkin
    David O. Okonkwo
    Bradley J. Molyneaux
    Neurocritical Care, 2016, 25 : 359 - 364
12345